resveratrol has been researched along with monocrotophos in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jahan, S; Khanna, VK; Kumar, D; Kumar, V; Pandey, A; Pant, AB; Rajpurohit, CS; Singh, S; Srivastava, A | 1 |
| Srivastava, P; Yadav, R | 1 |
2 other study(ies) available for resveratrol and monocrotophos
| Article | Year |
|---|---|
Resveratrol Prevents the Cellular Damages Induced by Monocrotophos via PI3K Signaling Pathway in Human Cord Blood Mesenchymal Stem Cells.
Topics: Adult; Annexin A5; Antioxidants; Biomarkers; Cell Death; Cytoprotection; Fetal Blood; Fluorescein-5-isothiocyanate; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mesenchymal Stem Cells; Mitochondria; Models, Biological; Monocrotophos; Neurons; Phosphatidylinositol 3-Kinases; Propidium; Protective Agents; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2018 |
Establishment of resveratrol and its derivatives as neuroprotectant against monocrotophos-induced alteration in NIPBL and POU4F1 protein through molecular docking studies.
Topics: Cell Cycle Proteins; Genes, cdc; Humans; Insecticides; Mesenchymal Stem Cells; Molecular Docking Simulation; Monocrotophos; Neurons; Neuroprotective Agents; Resveratrol; Transcription Factor Brn-3A | 2020 |